Ironwood Pharmaceuticals | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Almirall EUR 146.82M 197.04M 2024-12
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amarin USD 36.9M 1.64M 2024-09
Ardelyx USD 76.07M 11.1M 2024-12
Astellas Pharma JPY 211.32B 13.99B 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Charles River Laboratories USD 177.8M 10.46M 2025-03
Exact Sciences USD 485M 114.56M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Incyte USD 325.69M 1.02M 2025-03
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
MacroGenics USD 27.81M 13.71M 2024-12
Moderna USD 212M 139M 2025-03
Myriad Genetics USD 135.7M 300K 2025-03
Pacira USD 86.78M 7.16M 2025-03
PTC Therapeutics USD 161.92M 77.24M 2025-03
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
Takeda JPY 295.87B 25.28B 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03



Ironwood Pharmaceuticals Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.